Cardiac Absoludy NT-proBNP
본문
NT-proBNP is used as a predictor of Heart Failure (HF). NT-proBNP is typically increased in patients with asymptomatic or symptomatic left ventricular dysfunction and are associated with Coronary Artery Disease (CAD) and myocardial ischemia.
ADVANTAGE
SPECTIFICATION
|
AMR |
15~10,000 pg/mL |
|
Test time |
5 Min |
|
Samples Type |
Serum and Plasma (Lithiumheparin and K₂-EDTA) |
|
Samples Volume |
50 uL |
|
Contact |
Cartridge_20EA |
|
Pretreatment_20EA |
|
|
Disposable Tip_24EA |
|
|
Code Chip_1EA |
|
|
Package Insert_1EA |
RESULT DATA
PROCEDURE
ADVANTAGE
SPECTIFICATION
|
AMR |
15~10,000 pg/mL |
|
Test time |
5 Min |
|
Samples Type |
Serum and Plasma (Lithiumheparin and K₂-EDTA) |
|
Samples Volume |
50 uL |
|
Contact |
Cartridge_20EA |
|
Pretreatment_20EA |
|
|
Disposable Tip_24EA |
|
|
Code Chip_1EA |
|
|
Package Insert_1EA |
RESULT DATA
PROCEDURE
